Limited Number of Passes Available | In-Person Only | $99 Until February 28
(Discount codes not applicable on Exhibit Hall passes)
EXHIBIT HALL & KEYNOTE PASS
WEDNESDAY, APRIL 2 | 4:40 – 6:10 pm
PLENARY KEYNOTE PRESENTATION:
From Bytes to Breakthroughs: Generative AI Driving the Future of Life Sciences and Healthcare
Sofia Guerra, Vice President, Bessemer Venture Partners
Subha Madhaven, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Global Metrics and Data Management, Pfizer Inc.
Sonya Makhni, MD, Medical Director, Mayo Clinic Platform
Generative AI has the potential to transform life sciences and deliver unprecedented insights, automation, and efficiency. But is it? This keynote panel brings together leaders from biopharma, healthcare, and emerging tech who are leveraging AI to advance drug discovery, diagnostics, and patient care. Panelists will share their own case studies and real-world applications and discuss how they’ve tackled challenges—both technical and cultural. Look beyond the hype curve to see how this technology is really being used now and where the next opportunities lie.
EXHIBIT HALL & KEYNOTE PRESENTATION SCHEDULE:
WEDNESDAY, APRIL 2
6:10 – 7:25 pm Exhibit Hall Open
4:40 – 6:10 pm Plenary Keynote Presentation
6:10 – 7:25 pm Welcome Reception in the Exhibit Hall with Poster Viewing
THURSDAY, APRIL 3
9:30 am – 5:45 pm Exhibit Hall Open
8:00 – 9:30 am Plenary Keynote Presentation
9:30 – 10:15 am Coffee & Networking in the Exhibit Hall with Poster Viewing
10:05 am Raffle Drawing: Apple Air Tags
1:35 – 2:25 pm Refreshments & Networking in the Exhibit Hall with Poster Viewing
4:30 – 5:45 pm Best of Show Awards Reception in the Exhibit Hall with Poster Viewing
5:30 pm Raffle Drawing: Apple AirPods
FRIDAY, APRIL 4
8:00 am – 2:30 pm Exhibit Hall Open
8:05 – 8:20 am Innovative Practices Awards
8:20 – 9:45 am Plenary Keynote Presentation
9:45 – 10:30 am Coffee Break in the Exhibit Hall with Poster Viewing
1:50 – 2:30 pm Refreshment Break in the Exhibit Hall with Poster Viewing
2:20 pm Raffle Drawing: Ring Doorbell
**Exhibit Hours Subject to Change**
THURSDAY, APRIL 3 | 8:00 – 9:30 am
PLENARY KEYNOTE PRESENTATION: Deep Learning for Antibiotic Discovery
James J. Collins, PhD, Termeer Professor, Medical Engineering & Science, Massachusetts Institute of Technology
In this presentation, we highlight the Antibiotics-AI Project, which is a multi-disciplinary, innovative research program that is leveraging MIT's strengths in artificial intelligence, bioengineering, and the life sciences to discover and design novel classes of antibiotics. The Antibiotics-AI Project is focused on developing, integrating, and implementing deep learning models and chemogenomic screening approaches: (1) to predict novel antibiotics from expansive chemical libraries with diverse properties, (2) to design de novo novel antibiotics based on learned structural and functional properties of existing and newly discovered antibiotics, and (3) to identify, using explainable deep learning models, the chemical structures and molecular mechanisms underlying the newly discovered and/or designed antibiotics. With these deep learning approaches, we are utilizing multi-scale computation to embrace and harness the complexity of biology and chemistry, so as to discover, design, and develop new classes of antibiotics, up through preclinical studies. Our platform has been designed so that it can be utilized and applied in a rapid fashion to emerging and re-emerging bacterial pathogens, including multidrug-resistant (MDR) bacteria and extensively drug-resistant (XDR) bacteria.
PLENARY KEYNOTE PRESENTATION: Generative AI, Aging Research and Robotics as a Platform for Drug Discovery: From Hype to Clinical Efficacy
Alex Zhavoronkov, PhD, Founder & CEO, Insilico Medicine
FRIDAY, APRIL 4 | 8:00 – 9:45 am
PLENARY KEYNOTE PRESENTATION: Scaling Genomic Medicine: Transforming Newborn Screening through Informatics and Innovation
Robert C. Green, MD, MPH, Professor and Director of Genomes2People Research, Mass General Brigham, Broad Institute, Ariadne Labs and Harvard Medical School
The BabySeq Project has pioneered the integration of genomic sequencing into newborn and childhood screening, uncovering unexpected risk variants and transforming healthcare delivery. This keynote explores the groundbreaking progress in genomic medicine, featuring real-world stories of families impacted by these discoveries. Learn about the informatics challenges and innovative solutions required to scale genomic screening for national and global implementation, reshaping the future of precision medicine.
PLENARY KEYNOTE PRESENTATION: Unlocking the Power of Machine Learning and Data-at-Scale to Deliver with Speed the Best Therapeutic Candidates
Justin M. Scheer, PhD, Vice President In Silico Discovery & Head, Molecular Computational Team, Johnson & Johnson Innovative Medicine
The challenges of high costs, lengthy timelines, and significant attrition have prompted our industry to integrate AI/ML into all aspects of the business. This presentation highlights J&J's strategic investments in AI/ML technologies to enhance the drug discovery processes, including molecule design and optimization. By investing in these technologies with a modality agnostic approach, J&J aims to tackle the hardest targets in drug discovery, ultimately increasing the success rate of delivering better molecules faster.
Limited Number of Passes Available | In-Person Only | $99 Until February 28
(Discount codes not applicable on Exhibit Hall passes)